Kristina Navrazhina

Kristina Navrazhina

Auto-generated profile, based on publicly available information

Kristina Navrazhina

Laboratory for Investigative Dermatology The Rockefeller University New York NY USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
KNKristina Navrazhina
Kristina Navrazhina
SGSandra Garcet
Sandra Garcet
JGJuana Gonzalez
Juana Gonzalez
DGDavid Grand
David Grand
JFJohn Frew
John Frew
JKJames G. Krueger
James G. Krueger

29 May 2019 in Experimental Dermatology
Verified
Journal Article
Open access
PDF file
JFJohn Frew
John Frew
KNKristina Navrazhina
Kristina Navrazhina
MMMeaghan Marohn
Meaghan Marohn
PLPei‐Ju C. Lu
Pei‐Ju C. Lu
JKJames G. Krueger
James G. Krueger
The precise pathogenic mechanisms in the development, persistence and worsening of hidradenitis suppurativa (HS) remain ill‐defined. This chronic inflammatory dermatosis displays a strong Th1 and Th17 inflammatory signature with elevated levels of TNF‐α, IL‐1β, IL‐17 and IFNγ in lesional and perilesional tissue. HS significantly differs to other chronic inflammatory dermatoses due to the development of hypertrophic scarring and dermal tunnels. The development of scarring and tunnels suggests that fibroblastic stromal cells (including myofibroblasts, fibroblasts, pericytes etc) may be involved in the development and progression of disease. Heterogeneous populations of fibroblasts have been identified in other inflammatory disorders and malignancy which contribute to inflammation and present novel therapeutic targets for fibrotic disorders. Findings in HS are consistent with these fibroblast subpopulations and may contribute to tunnel formation, aggressive squamous cell carcinoma and the phenotypic presentation of familial HS variants. We describe the existing knowledge regarding these mechanistic pathways and methods to confirm their involvement in the pathogenesis of HS.

2 June 2022 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
KNKristina Navrazhina
Kristina Navrazhina
JFJohn Frew
John Frew
DGDavid Grand
David Grand
SWSamuel C. Williams
Samuel C. Williams
HHHong Hur
Hong Hur
JKJames G. Krueger
James G. Krueger

8 August 2020 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
JFJohn Frew
John Frew
KNK. Navrazhina
K. Navrazhina
MSM. Sullivan‐Whalen
M. Sullivan‐Whalen
PGP. Gilleaudeau
P. Gilleaudeau
SGS. Garcet
S. Garcet
JKJ.G. Krueger
J.G. Krueger

26 September 2019 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
KNK. Navrazhina
K. Navrazhina
JFJohn Frew
John Frew
JKJ.G. Krueger
J.G. Krueger

29 June 2020 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
DGD. Grand
D. Grand
JFJohn Frew
John Frew
KNK. Navrazhina
K. Navrazhina
JKJ.G. Krueger
J.G. Krueger